Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Short-term Investments: 2016-2021

Historic Short-term Investments for Aytu Biopharma (AYTU) over the last 6 years, with Jun 2021 value amounting to $252,000.

  • Aytu Biopharma's Short-term Investments changed negligibly% to $252,000 in Q3 2021 from the same period last year, while for Sep 2021 it was $252,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $252,000 for FY2021, which is 0.40% up from last year.
  • Per Aytu Biopharma's latest filing, its Short-term Investments stood at $252,000 for FY2021, which was up 0.40% from $251,000 recorded in FY2020.
  • In the past 5 years, Aytu Biopharma's Short-term Investments registered a high of $252,000 during FY2021, and its lowest value of $75,214 during FY2017.
  • For the 3-year period, Aytu Biopharma's Short-term Investments averaged around $251,000, with its median value being $251,000 (2020).
  • Its Short-term Investments has fluctuated over the past 5 years, first crashed by 92.78% in 2017, then spiked by 150.00% in 2019.
  • Over the past 5 years, Aytu Biopharma's Short-term Investments (Yearly) stood at $75,214 in 2017, then soared by 32.95% to $100,000 in 2018, then skyrocketed by 150.00% to $250,000 in 2019, then increased by 0.40% to $251,000 in 2020, then climbed by 0.40% to $252,000 in 2021.